Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Forum of Clinical Oncology
Volume 13 (2022): Issue 3 (December 2022)
Open Access
A Case Report on Zoledronic Acid as Palliative Treatment in Carcinoma of Lung with Bone Metastasis
Y. Sandhya
Y. Sandhya
,
M. Swathi
M. Swathi
,
G. Yeshavanth
G. Yeshavanth
and
V.T. Nagaraja
V.T. Nagaraja
| Jul 04, 2023
Forum of Clinical Oncology
Volume 13 (2022): Issue 3 (December 2022)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Case Report
Published Online:
Jul 04, 2023
Page range:
49 - 51
Received:
Sep 08, 2022
Accepted:
Jan 26, 2023
DOI:
https://doi.org/10.2478/fco-2023-0001
Keywords
zoledronic acid
,
palliative treatment
,
bone metastasis
,
lung cancer
© 2023 Y. Sandhya et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1.
PET-CT scan from vertex to mid-thigh.a. Neck: Thrombosis of right IJV, right subclavian, and axillary veins with adjacent soft tissue standing.b. Chest: 4.4×3 cm pleural based metabolically active soft tissue in the right upper lobe abutting the adjacent diaphragmatic pleural, likely of neoplastic etiology. Peripheral lung nodule in the apical segment of right lower lobe: metastasisc. Musculoskeletal: Metabolically active lytic lesion involving the left posterior 2nd rib. Degenerative changes are noted in spine.Histopathology report: Left rib lesion biopsy. Features are of metastatic squamous cell carcinoma.
Figure 2.
Pain score before treatment with zoledronic acid.
Figure 3.
Pain score after treatment with zoledronic acid.